Hamartoma secondary prevention

	Hamartoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamartoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hamartoma secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hamartoma secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hamartoma secondary prevention
CDC on Hamartoma secondary prevention
Hamartoma secondary prevention in the news
Blogs on Hamartoma secondary prevention
Directions to Hospitals Treating Hamartoma
Risk calculators and risk factors for Hamartoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Secondary prevention strategy for multiple hamartoma syndromes includes periodical imaging surveillance with CT scan.^[1]

Secondary prevention strategy for multiple hamartoma syndromes includes periodical imaging surveillance with CT scan.^[1]

↑ ^1.0 ^1.1 Amini B, Huang SY, Tsai J, Benveniste MF, Robledo HH, Lee EY (2013). "Primary lung and large airway neoplasms in children: current imaging evaluation with multidetector computed tomography". Radiol. Clin. North Am. 51 (4): 637–57. doi:10.1016/j.rcl.2013.04.005. PMID 23830790.